Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ales Mrhar
Population Pharmacokinetics of Rituximab in Patients With Diffuse Large B-Cell Lymphoma and Association With Clinical Outcome
British Journal of Clinical Pharmacology
Pharmacology
Related publications
Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma
Annals of Hematology
Medicine
Hematology
Clinical Significance of T-Cell Exhaustion in Patients With Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Statin Use and Prognosis in Patients With Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in the Rituximab Era
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
The Kyoto Prognostic Index for Patients With Diffuse Large B-Cell Lymphoma in the Rituximab Era
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Rituximab, Lenalidomide, and Ibrutinib Alone and Combined With Chemotherapy for Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Primary Breast Diffuse Large B-Cell Lymphoma. Clinical Features and Outcome in 55 Patients. Polish Lymphoma Research Group Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
A Phase II Trial of Bendamustine in Combination With Rituximab in Older Patients With Previously Untreated Diffuse Large B-Cell Lymphoma
British Journal of Haematology
Hematology
Prognostic Significance of Survivin and Caspase-3 Immunohistochemical Expression in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab and CHOP
Pathology and Oncology Research
Medicine
Forensic Medicine
Pathology
Oncology
Cancer Research
High-Risk Patients With Diffuse Large B-Cell Lymphoma Are Not Enrolled on Clinical Trials
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
